EUVIMEDEUVIMED entdecken
Crossref

Malignant Head and Neck Paraganglioma: A Comprehensive and Contemporary Database Review of a Rare Entity

Avigeet Gupta iD, Kadie M Nausha iD, Alexander G Bien iD, Rachad I Mhawej iD

Clinical Otolaryngology · 2026

DOI: 10.1111/coa.70147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Otolaryngology, 2026. Verfasst von Avigeet Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Paraganglioma. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

There remains an overall paucity of literature regarding malignant head and neck paragangliomas (MHNPs) and optimal treatment strategies. Our study aims to elucidate contemporary trends regarding the incidence, management modalities, and predictors of survival in a rare entity of a malignancy for which there is no well‐established treatment guideline.

Design

The Surveillance, Epidemiology, and End Results (SEER) database was queried for all cases of MHNPs from 2000 to 2019.

Results

The age‐adjusted incidence of MHNPs has increased 56% from 2000 to 2019 (0.096–0.150 per 1 000 000). One hundred forty‐two patients were included for case‐listed statistical analysis, with the mean age at diagnosis being 47 years ± 18.4, presence of regional disease in 47% of cases, and distant disease in 53%. Surgery was the most common form of treatment for MHNP (90, 63.4%) followed by radiation (57, 40.1%). Two‐year and 5‐year disease‐specific survival were noted to be 92% and 79%, respectively. Patients treated with surgery had a decreased risk of mortality (0.227 [95% CI: 0.122–0.424], p < 0.001), whereas those with distant disease at diagnosis had an increased risk of mortality (3.47 [95% CI: 1.780–6.800], p < 0.001).

Conclusion

This study represents the largest and most contemporary known cohort of patients with MHNP and provides details regarding the incidence, survival, and treatment strategies for this rare malignancy with little known treatment data. There was a statistically significant benefit for surgical management of MHNP. Distant metastasis at diagnosis was an independent predictor of increased mortality risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsParagangliomaHumansFemaleMiddle AgedMaleIncidenceAdultSEER ProgramSurvival RateAgedUnited States

Autor:innen und Institutionen

  • Department of Otolaryngology - Head and Neck Surgery, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

ORCID-Profile: Avigeet Gupta, Kadie M Nausha, Alexander G Bien, Rachad I Mhawej

Zitieren

APA

Gupta, A., Nausha, K. M., Bien, A. G., & Mhawej, R. I. (2026). Malignant Head and Neck Paraganglioma: A Comprehensive and Contemporary Database Review of a Rare Entity. Clinical Otolaryngology. https://doi.org/10.1111/coa.70147

Vancouver

Gupta A, Nausha KM, Bien AG, Mhawej RI. Malignant Head and Neck Paraganglioma: A Comprehensive and Contemporary Database Review of a Rare Entity. Clinical Otolaryngology. 2026. doi:10.1111/coa.70147

BibTeX
@article{Gupta2026,
  author = {Gupta, Avigeet and Nausha, Kadie M and Bien, Alexander G and Mhawej, Rachad I},
  title = {Malignant Head and Neck Paraganglioma: A Comprehensive and Contemporary Database Review of a Rare Entity},
  journal = {Clinical Otolaryngology},
  year = {2026},
  doi = {10.1111/coa.70147}
}
Kostenlos starten →